Novel Crispr Enzymes And Systems

Patent No. EP3310917 (titled "Novel Crispr Enzymes And Systems") was filed by Massachusetts Institute OF Technology on Jun 17, 2016. The application was issued on Sep 3, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BOULT WADE TENNANTNov 12, 2020BOULT WADE TENNANT
JAMES POOLENov 11, 2020CARPMAELS & RANSFORD
STRAWMANNov 11, 2020POTTER CLARKSON
NEUEFEINDSep 25, 2020MAIWALD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3310917

MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Application Number
EP16734803A
Filing Date
Jun 17, 2016
Status
Patent Maintained As Amended
Aug 1, 2025
Publication Date
Sep 3, 2025